13th Annual Scottsdale Prostate Cancer Symposium 2008 February 28 - March 2, 2008 Camelback Inn, A JW Marriott Resort and Spa Scottsdale, Arizona

Target Audience This course is intended for urologists, radiation oncologists, radiologists, medical oncologists, pathologists, physicians, dosimetrists, and nurses. It will educate the registrants about advances in management of localized and advanced prostate cancer. . Course Objectives The program is designed to maximize the educational component and also allow for adequate time to explore the unrivaled beauties of Southwest Arizona in the spring. At the conclusion of this activity, participants will be able to: • Describe the technique of real-time dose-moderated brachytherapy • Explain the technique of robotic prostatectomy • Identify uses of robotic radical prostatectomy • Identify appropriate patients for brachytherapy and IMRT/IGRT therapy • Explain how to determine which patients are appropriate for robotic, open prostatectomy or salvage therapies • Describe the potential benefits of chemotherapy in patients with locally advanced and hormone refractory prostate cancer • Identify appropriate uses of image-guided external beam radiotherapy • Explain the role of treatment with bisphosphonates in advanced prostate cancer • Identify appropriate uses of 3-D mapping for prostate biopsy • Identify the role of metabolic syndrome in patients in androgen withdrawal • Describe the use of nutritional supplements (nutricals) in men with prostate cancer • Identify appropriate uses of computer-guided brachytherapy   Accreditation Statement This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and Diversified Conference Management, Inc. (DCMI). PIM is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation Postgraduate Institute for Medicine designates this educational activity for a maximum of 20.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Disclosure of Conflicts of Interest Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. .   Jointly Sponsored by Postgraduate Institute for Medicine and Diversified Conference Management, Inc.   . This course is supported in part by an educational grant from: B-K Medical Systems, Inc. Sanofi-Aventis TAP Pharmaceuticals   Exhibitors: Bard Urological Computerized Medical Systems, Inc. Dendreon Indevus Pharmaceuticals TAP Pharmaceuticals - Prostate   Home | About Us | Contact Prostate | Faculty | Agenda | Information | Hotel | Registration   Copyright ©2001. All Rights Reserved. Last Revised 2-22-08